Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Plexxikon Wins Tafinlar Patent Dispute Case Against Novartis

Jul 23 2021

• By Joseph Haas

Patent Law Concept 3D Illustration — District Court patent infringement decision brings Plexxikon $178m in damages

Related Content

Novartis in $28.5bn+ mega-deal with GSK, Lilly

Apr 22 2014

Deal completion sees Plexxikon become part of Daiichi Sankyo

Apr 06 2011

Plexxikon, Roche Near Catalyst For BRAF Inhibitor In Melanoma

Jan 06 2011

Related Companies

Plexxikon, Inc.

Novartis AG

Daiichi Sankyo Co., Ltd.

GSK plc

Roche Holding AG

Additional Topics

Intellectual Property Legal Issues Companies Commercial Cancer BioPharmaceutical

More from Legal & IP

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window